Skip to main navigation Skip to search Skip to main content

Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

    Research output: Contribution to journalArticleScientificpeer-review

    40 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1491-1496
    JournalGraefe's Archive for Clinical and Experimental Ophthalmology
    Volume244
    DOIs
    Publication statusPublished - 2006
    Publication typeA1 Journal article-refereed

    Cite this